Telomerase and telomere stability: A new class of tumor suppressor?

Molecular Carcinogenesis

Volumn 28, Issue 1, 2000, Pages 1-4

  Elmore, Lynne W ^a   Holt, Shawn E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Immortalization; Senescence; Telomerase; Telomere

Indexed keywords

TELOMERASE;

ARTICLE; CANCER INHIBITION; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL PROTECTION; GENE MUTATION; HUMAN; HUMAN CELL; LIFESPAN; MALIGNANT TRANSFORMATION; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; TELOMERE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; ENZYME STABILITY; GENES, TUMOR SUPPRESSOR; HUMANS; TELOMERASE; TELOMERE;

EID: 0034082601     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(200005)28:1<1::AID-MC1>3.0.CO;2-N     Document Type: Article

References (19)

1. Wright WE, Shay JW. The two-stage mechanism controlling cellular senescence and immortalization. Exp Gerontol 1992;27:383-389.
2. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-2015.
3. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997;33:787-791.
4. Morales CP, Holt SE, Ouellette M, et al. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Gen 1999;21:55-58.
5. Jiang Z-R, Jimenez G, Chang E, et al. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Gen 1999;21:111-114.
6. Foster SA, Galloway DA. Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells. Oncogene 1996;12: 1773-1779.
7. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ. Both Rb/p16ink4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998;396:84-88.
8. Moyzis RK, Buckingham JM, Cram S, et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988;85:6622-6626.
9. de Lange T, Shiue L, Meyers RM, et al. Structure and variability of human chromosome ends. Mol Cell Biol 1990;10: 518-527.
10. Harley CB, Futcher AB, Greider CW. Telomeres shorten with aging. Nature 1990;345:458-460.
11. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990;346: 866-868.
12. Greider CW, Blackburn EH. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 1989;337:331-337.
13. Feng J, Funk WD, Wang S-S, et al. The RNA component of human telomerase. Science 1995;269:1236-1241.
14. Weinrich SL, Pruzan R, Ma L, et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 1997;17: 498-502.
15. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life span by introduction of telomerase into normal human cells. Science 1998;279:349-352.
16. Vaziri H, Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 1998;8:279-282.
17. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumor cells with defined genetic elements. Nature 1999;400:464-468.
18. Harrington LA, Greider CW. Telomerase primer specificity and chromosome healing. Nature 1991;353:451-454.
19. Yu G-L, Blackburn EH. Developmentally programmed healing of chromosomes by telomerase in Tetrahymena. Cell 1991;67:823-832.